InnoCare Tightens Audit Committee Rules to Bolster Governance

An announcement from InnoCare Pharma Ltd. ( (HK:9969) ) is now available.

InnoCare Pharma Limited has formalized the terms of reference for its audit committee, a governance body first established by the board in September 2019, to align with Hong Kong Listing Rules and the applicable rules of the STAR Market. The document specifies that the committee must comprise at least three non-executive directors, with a majority being independent and at least one possessing appropriate accounting or financial management expertise, and it also bars former partners of the current audit firm from joining the committee for two years after leaving or divesting their interest, reinforcing auditor independence and corporate governance standards.

These enhanced audit committee requirements signal InnoCare’s ongoing efforts to strengthen financial oversight and compliance across its dual listings in Hong Kong and Shanghai, which may bolster investor confidence and align the company with best practices in risk management and transparency. By clearly defining membership criteria, quorum rules and independence safeguards, the company underscores its commitment to robust board-level supervision of financial reporting and audit processes, an increasingly critical factor for stakeholders in China’s and Hong Kong’s biopharmaceutical capital markets.

The most recent analyst rating on (HK:9969) stock is a Hold with a HK$11.50 price target. To see the full list of analyst forecasts on InnoCare Pharma Ltd. stock, see the HK:9969 Stock Forecast page.

More about InnoCare Pharma Ltd.

InnoCare Pharma Limited is a biotechnology and pharmaceutical company focused on developing innovative therapies, and its shares are listed in Hong Kong and on the STAR Market of the Shanghai Stock Exchange. The group structure includes the company, its subsidiaries and associated companies, indicating a cross-border capital markets presence and regulatory oversight in both Hong Kong and mainland China.

Average Trading Volume: 6,876,447

Technical Sentiment Signal: Sell

Current Market Cap: HK$17.58B

For an in-depth examination of 9969 stock, go to TipRanks’ Overview page.